The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An open-label, phase II basket study of olaparib and durvalumab (MEDIOLA): Results in patients with relapsed gastric cancer.
 
Yung-Jue Bang
Consulting or Advisory Role - AstraZeneca/MedImmune; Bayer; BeiGene; Green Cross; Hanmi; Merck Serono; MSD Oncology; Novartis; Samyang; Taiho Pharmaceutical
Research Funding - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); BeiGene (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Chong Kun Dang Pharmaceutical (Inst); Curis (Inst); Daiichi Sankyo (Inst); Five Prime Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Green Cross (Inst); Lilly (Inst); Macrogenics (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Bella Kaufman
Honoraria - AstraZeneca; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Novartis; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Medison; Pfizer; Roche
 
Ravit Geva
Honoraria - Bristol-Myers Squibb; Janssen; Lilly; Medison; MSD; Novartis; Pfizer; Roche; Teva
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Salomon M. Stemmer
Consulting or Advisory Role - Novartis
Research Funding - multiple (Inst)
Travel, Accommodations, Expenses - Genomic Health
 
Sook-Hee Hong
No Relationships to Disclose
 
Jong-Seok Lee
No Relationships to Disclose
 
Susan M. Domchek
Honoraria - AstraZeneca; Bristol-Myers Squibb; Clovis Oncology
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Pharmamar (Inst)
 
Mark C. Lanasa
Employment - Immunocore; MedImmune
 
Mei Tang
Employment - AstraZeneca/MedImmune
 
Christopher Gresty
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Helen K Angell
Employment - AstraZeneca/MedImmune
Stock and Other Ownership Interests - AstraZeneca/MedImmune
Research Funding - AstraZeneca/MedImmune
 
Laura L.M. Opincar
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Pia Maarit Herbolsheimer
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
T.R. Jeffry Evans
Honoraria - Bristol-Myers Squibb; Eisai
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Eisai; Karus Therapeutics
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Eisai
Research Funding - AstraZeneca (Inst); Basilea (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Immunocore (Inst); Lilly (Inst); Merck (Inst); Nutide (Inst); Ono Pharmaceutical (Inst); Roche (Inst); Sierra Pharma (Inst); Verastem (Inst); Vertex (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb